[ Price : $8.95]
Federal Register notice: FDA announces a 3/21/2018 public meeting on Prescription Drug User Fee Act of 2017; Electronic Submission...[ Price : $8.95]
FDA medical reviewers say Aeries Rhopressa is effective in lowering eye pressure in some patients.[ Price : $8.95]
FDA denies an AstraZeneca petition asking that the agency rule on specific aspects of a 505(b)(2) NDA referencing Falsodex IM inje...[ Price : $8.95]
The PriceWaterhouseCoopers Health Research Institute says that drug companies face a growing threat from FDA changes to the collec...[ Price : $8.95]
FDA issues a draft guidance explaining the user fee structures and types of fees under the PDUFA 6 reauthorization.[ Price : $8.95]
FDA publishes a draft guidance to help sponsors choose the appropriate abbreviated approval pathway and understand what data and i...[ Price : $8.95]
Merck says it will not seek FDA regulatory approval for anacetrapib, an investigational cholesteryl ester transfer protein inhibit...[ Price : $8.95]
FDA releases a draft guidance on the procedures for ANDA applicants to resolve scientific or regulatory disputes with FDA at the a...